Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection
WOBURN, Mass. May 6, 2024 – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products...
More Than 200 Insulin Pump Users Injured After App Causes Malfunction
The U.S. Food and Drug Administration has issued a Class 1 recall -- its most urgent kind -- for an IOS app linked to a specific kind of insulin pump used...
Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved...
Symptom Burden Prevalent in Childhood Cancer Survivors
Symptom burden is prevalent among young childhood cancer survivors, with caregiver anxiety and greater neighborhood deprivation associated with greater...
High Rates of Harassment Behaviors Observed in Obstetrics and Gynecology
There are high rates of harassment behaviors within the obstetrics and gynecology (OB-GYN) specialty, according to a review published online May 8 in JAMA...
Thrombectomy Linked to Better Outcomes for Acute Stroke, Large Infarct
For patients with acute stroke and a large infarct, thrombectomy plus medical care results in better functional outcomes and lower mortality, according...
Rapid Procedure Noninferior for Extended-Release Naltrexone Initiation
For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of extended-release (XR) naltrexone,...
More Data Suggests 'Ultraprocessed' Foods Can Shorten Your Life
People who eat large amounts of ultra-processed foods have a slightly higher risk of premature death than those who mostly shun the industrially produced...
Neuropathy Nerve Damage Often Goes Undiagnosed
THURSDAY, May 9, 2024 — Though it is a widespread disorder, neuropathy often goes undiagnosed, new research shows, leaving many people at risk of...
There's a New Set of COVID Variants Called FLiRT: What You Need to Know
The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported. The...
Bayer to Unveil Late-Breaking Data from Phase III OASIS 1 and 2 for Elinzanetant in the Treatment of Vasomotor Symptoms Associated with Menopause
Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2 evaluating the efficacy and safety of the investigational compound...
Faster Approach for Starting Extended-Release Naltrexone to Treat Opioid Use Disorder Shown Effective
Starting people with opioid use disorder on extended-release, injectable naltrexone (XR-naltrexone) within five to seven days of seeking treatment is more...
Recently Added
Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
- Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
- Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...